Не знаю

Мне вот тоже интересно. Будет инфа, маякните

Для тех кто не умеет пользоваться Гуглом 10th August 2022 Sanofi Sanofi has announced that enrolment for international phase 3 trials assessing tolebrutinib as a treatment for multiple sclerosis (MS) have been paused. However, the company has confirmed that, despite the pause, US studies are still going ahead.

Хз

@sakaime1 спасибо 👌